Cellosaurus logo
expasy logo

Cellosaurus NCC-OS1-X2-C1 (CVCL_VM08)

[Text version]
Cell line name NCC-OS1-X2-C1
Synonyms NCC-OS1-C1; NCCOS1X2C1
Accession CVCL_VM08
Resource Identification Initiative To cite this cell line use: NCC-OS1-X2-C1 (RRID:CVCL_VM08)
Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: NCC sarcoma cell line panel.
Population: Japanese.
Characteristics: Established from a second generation xenograft established by subcutaneous injection in female SCID mice.
Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
Doubling time: 29 hours (PubMed=29943355).
Omics: Deep proteome analysis.
Derived from site: In situ; Bone, distal femur; UBERON=UBERON_0004406.
Sequence variations
Disease Osteosarcoma (NCIt: C9145)
Osteosarcoma (ORDO: Orphanet_668)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 11Y
Category Cancer cell line
STR profile Source(s): PubMed=29943355

Markers:
AmelogeninX
CSF1PO11
D5S81812
D7S82010,11
D13S3178,10
D16S53911
D21S1130
TH019
TPOX8,11
vWA16,18

Run an STR similarity search on this cell line
Web pages https://en.cellline.jp/product/ncc-os1-x2-c1/
Publications

PubMed=29943355; DOI=10.1007/s11626-018-0274-2
Kito F., Oyama R., Sakumoto M., Takahashi M., Shiozawa K., Qiao Z.-W., Sakamoto H., Hirose T., Setsu N., Yoshida A., Kawai A., Kondo T.
Establishment and characterization of novel patient-derived osteosarcoma xenograft and cell line.
In Vitro Cell. Dev. Biol. Anim. 54:528-536(2018)

DOI=10.2198/jelectroph.65.1
Noguchi R., Yoshimatsu Y., Ono T., Sei A., Kondo T.
Proteogenomic approach to drug targets in osteosarcomas with different original sites.
J. Electroph. 65:1-11(2021)

Cross-references
Cell line databases/resources cancercelllines; CVCL_VM08
DepMap; ACH-002778
Encyclopedic resources Wikidata; Q95992540
Entry history
Entry creation07-Sep-2018
Last entry update30-Jan-2024
Version number10